In this free webinar, gain insights into the invaluable and increasing role of protein biomarkers in healthcare. The featured speakers will discuss the critical steps and considerations in the biomarker development pipeline. The speakers will also discuss how innovative multiplex technologies are facilitating the journey from biomarker discovery to clinical utility while delivering reproducible insights into health and disease.
TORONTO, Oct. 29, 2024 /PRNewswire-PRWeb/ -- Biomarkers such as ribonucleic acid (RNA), deoxyribonucleic acid (DNA), proteins, lipids and other biomolecules are playing an increasingly vital role in advancing our understanding of health, driving drug development and improving clinical trial outcomes.
Among these, protein biomarkers are particularly significant, as they regulate many of the body's biological functions and act as targets for most existing drugs, positioning them as central players in the advancement of personalized medicine.
In recent years, protein signatures comprising several biomarkers have led to critical breakthroughs in identifying disease subtypes, enabling earlier diagnoses and monitoring treatment response by offering a real-time, comprehensive view of disease complexity. However, the growing use and reliance on protein biomarkers highlights the need for a robust and efficient development pipeline to address key challenges such as:
- Ensuring reliable protein measurements that capture true biological signals and yield reproducible data
- Applying relevant statistical analysis for detecting meaningful differences between groups and streamlining actionable insights
- Utilizing scalable approaches throughout all stages of biomarker development
Addressing these challenges in biomarker development requires a robust, scalable and highly sensitive multiplex analysis platform using rigorously and transparently validated protein biomarker assays. This approach will be critical for shortening the time from discovery to clinical application, reducing costs and ensuring the identification of reliable biomarkers and drug targets for improved health outcomes.
Register for this informative webinar to understand the critical role of protein biomarkers in advancing personalized medicine and improving clinical trial outcomes.
Join experts from Olink, part of Thermo Fisher Scientific, Lena Eriksson, Group Manager Assay Development; and Katarina Hörnaeus, Product Portfolio Director, for the live webinar on Monday, November 18, 2024, at 9am EST (3pm CET/EU-Central).
For more information, or to register for this event, visit What is a Good Biomarker?
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article